Rule 8.3- Cambridge Antibody
May 22 2006 - 9:37AM
UK Regulatory
RNS Number:3579D
Credit Suisse Securities (Eur) Ltd
22 May 2006
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note 1) Credit Suisse Securities (Europe) Ltd
Company dealt in Cambridge Antibody Tech Group Plc
Class of relevant security to which the Ordinary Shares
dealings being disclosed relate (Note 2)
Date of dealing 19 May 2006
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 536,461 (1.0085%)
(2) Derivatives (other than options)
(3) Options and agreements to purchase/
sell
Total 536,461 (1.0085%)
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
(GBP)
Sell 1,917 12.97
(b) Derivatives transactions (other than options)
Product name, Long/short (Note Number of securities Price per unit
e.g. CFD 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option
name,e.g. selling, securities price American, date money paid/
call purchasing, to which European received
option varying etc. the option etc. per unit
relates (Note 5)
(Note 7)
(ii) Exercising
Product name, e.g. Number of securities Exercise price per unit (Note 5)
call option
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit (if
applicable) (Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
..............................................................................
None
..............................................................................
Is a Supplemental Form 8 attached? (Note 9) No
Date of disclosure 22 May 2006
Contact name Dan Smith
Telephone number 020 7883 7834
If a connected EFM, name of offeree/offeror with N/A
which connected
If a connected EFM, state nature of connection N/A
(Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETFGGZKDZVGVZM
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024